Jefferies downgraded Bausch Health (BHC) to Hold from Buy.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHC:
- Bausch Health call volume above normal and directionally bullish
- Bausch Health Retains Bausch + Lomb, Explores New Financial Strategies
- Bausch Health board determines not to move forward with Bausch + Lomb sale
- Bausch Health price target lowered to $10 from $11 at RBC Capital
- Bausch Health’s XIFAXAN Selected for Medicare Price Negotiation